Ignite Creation Date:
2025-12-24 @ 12:07 PM
Ignite Modification Date:
2025-12-31 @ 8:28 PM
Study NCT ID:
NCT01492361
Status:
COMPLETED
Last Update Posted:
2022-04-14
First Post:
2011-12-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin
Sponsor:
Amarin Pharma Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AMR-01-01-0019
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None